995 resultados para Defense Technical Information Center (U.S.)


Relevância:

100.00% 100.00%

Publicador:

Resumo:

The famous University of Michigan medical center at Ann Arbor, Michigan is widely known and recognized as a leader in the field of medical treatment, education and research.

Relevância:

100.00% 100.00%

Publicador:

Resumo:

Founded in 1869, this facility was America's first "University Hospital." The 1,000-bed general hospital, with its 200-bed children's hospital (C.S. Mott Hospital), is the heart of a vast health complex which includes School of Medicine, Nursing and Public Health...plus research facilities. The Mary Markley dormitory building may be seen in the foreground.

Relevância:

100.00% 100.00%

Publicador:

Resumo:

"The United States ... as part of the NATO/CCMS Air Pollution Pilot Study, introduced the Low Pollution Power Systems Development (LPPSD) program."

Relevância:

100.00% 100.00%

Publicador:

Resumo:

Mode of access: Internet.

Relevância:

100.00% 100.00%

Publicador:

Resumo:

ERIC is an information system sponsored by the National Institute of Education, Department of Education, United States acquires, selects, summarizes, indexes, processes and disseminates information that is generated and produced in the field of education.ERIC was founded in 1966 with the purpose of controlling and collecting the literature of education and research and technical reports, conferences, studies by commissions and committees, descriptions of projects and programs, lectures, speeches and the like.

Relevância:

100.00% 100.00%

Publicador:

Resumo:

This single center study is the largest series of renal transplant recipients and donors screened for the commonest prothrombotic genotypes. A total of 562 transplant recipients and 457 kidney donors were genotyped for the factor V Leiden and prothrombin G20210A mutations. The prevalence of heterozygous factor V Leiden was 3.4% and 2.6% and prothrombin G20210A was 2.0% and 1.1% in recipients and donors, respectively, similar frequencies to that of the general U.K. population. The 30-day and 1-year graft survival rates in recipients with thrombophilic mutations were 93% and 93%, compared with 88% and 82% in patients without these mutations (log-rank P =0.34). Thrombophilia in recipients (odds ratio 0.55; confidence interval 0.06-2.29; P =0.56) or in donors (odds ratio 1.53; confidence interval 0.27-5.74; P =0.46) did not correlate with graft loss at 30 days after transplantation. In contrast to recent reports, this study did not demonstrate an association between thrombophilia and renal allograft loss, and routine screening is not recommended.